The evolution of hyperprolactinaemia as an entity in psychiatric patients.
about
Cancer and schizophrenia: is there a paradox?A Role for the Transcription Factor Nk2 Homeobox 1 in Schizophrenia: Convergent Evidence from Animal and Human StudiesAntipsychotics and hyperprolactinaemia: mechanisms, consequences and management.A critical review of major mortality risk factors for all-cause mortality in first-episode schizophrenia: clinical and research implications.Prevalence and risk factors of hyperprolactinemia among patients with various psychiatric diagnoses and medications.
P2860
The evolution of hyperprolactinaemia as an entity in psychiatric patients.
description
2008 nî lūn-bûn
@nan
2008 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մարտին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
The evolution of hyperprolactinaemia as an entity in psychiatric patients.
@en
The evolution of hyperprolactinaemia as an entity in psychiatric patients.
@nl
type
label
The evolution of hyperprolactinaemia as an entity in psychiatric patients.
@en
The evolution of hyperprolactinaemia as an entity in psychiatric patients.
@nl
prefLabel
The evolution of hyperprolactinaemia as an entity in psychiatric patients.
@en
The evolution of hyperprolactinaemia as an entity in psychiatric patients.
@nl
P2860
P356
P1476
The evolution of hyperprolactinaemia as an entity in psychiatric patients.
@en
P2093
Dora Kohen
Hiram Joseph Wildgust
P2860
P356
10.1177/0269216307087147
P407
P433
P577
2008-03-01T00:00:00Z